Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pullinger

Showing results (301-310 of 317) with videos related to

Pageof 32
Sort By:
The New England Journal of Medicine|April 13, 2017
Autoantibodies against GPIHBP1 as a Cause of HypertriglyceridemiaAnne P Beigneux, Kazuya Miyashita, Michael Ploug, et al.
Elife|October 17, 2015
An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafishJun Zou, Diana Tran, Mai Baalbaki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Galanin preproprotein is associated with elevated plasma triglyceridesChristopher L Plaisier, Mira Kyttälä, Daphna Weissglas-Volkov, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Nature Medicine|January 10, 2024
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer ProgrammeAlona Sosinsky, John Ambrose, William Cross, et al.
American Journal of Human Genetics|April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasisCatherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|August 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomesAshlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Microbiology Spectrum|November 29, 2023
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
American Journal of Human Genetics|August 5, 2008
WW-domain-containing oxidoreductase is associated with low plasma HDL-C levelsJenny C Lee, Daphna Weissglas-Volkov, Mira Kyttälä, et al.
Pageof 32

Showing results (301-310 of 317) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|April 13, 2017
Autoantibodies against GPIHBP1 as a Cause of HypertriglyceridemiaAnne P Beigneux, Kazuya Miyashita, Michael Ploug, et al.
Elife|October 17, 2015
An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafishJun Zou, Diana Tran, Mai Baalbaki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Galanin preproprotein is associated with elevated plasma triglyceridesChristopher L Plaisier, Mira Kyttälä, Daphna Weissglas-Volkov, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Nature Medicine|January 10, 2024
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer ProgrammeAlona Sosinsky, John Ambrose, William Cross, et al.
American Journal of Human Genetics|April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasisCatherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|August 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomesAshlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Microbiology Spectrum|November 29, 2023
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
American Journal of Human Genetics|August 5, 2008
WW-domain-containing oxidoreductase is associated with low plasma HDL-C levelsJenny C Lee, Daphna Weissglas-Volkov, Mira Kyttälä, et al.
Pageof 32